Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Help & Advice
University of Warwick

The Library

  • Login
  • Admin

Engineered RNA-interacting CRISPR guide RNAs for genetic sensing and diagnostics

Tools
- Tools
+ Tools

Galizi, Roberto, Duncan, John, Rostain, William, Quinn, Charlotte M., Storch, Marko, Kushwaha, Manish and Jaramillo, Alfonso (2020) Engineered RNA-interacting CRISPR guide RNAs for genetic sensing and diagnostics. The CRISPR Journal, 3 (5). pp. 398-408. doi:10.1089/crispr.2020.0029 ISSN 2573-1602.

Research output not available from this repository.

Request-a-Copy directly from author or use local Library Get it For Me service.

Official URL: https://doi.org/10.1089/crispr.2020.0029

Request Changes to record.

Abstract

CRISPR guide RNAs (gRNAs) can be programmed with relative ease to allow the genetic editing of nearly any DNA or RNA sequence. Here, we propose novel molecular architectures to achieve RNA-dependent modulation of CRISPR activity in response to specific RNA molecules. We designed and tested, in both living Escherichia coli cells and cell-free assays for rapid prototyping, cis-repressed RNA-interacting guide RNA (igRNA) that switch to their active state only upon interaction with small RNA fragments or long RNA transcripts, including pathogen-derived mRNAs of medical relevance such as the human immunodeficiency virus infectivity factor. The proposed CRISPR-igRNAs are fully customizable and easily adaptable to the majority if not all the available CRISPR-Cas variants to modulate a variety of genetic functions in response to specific cellular conditions, providing orthogonal activation and increased specificity. We thereby foresee a large scope of application for therapeutic, diagnostic, and biotech applications in both prokaryotic and eukaryotic systems.

Item Type: Journal Article
Divisions: Faculty of Science, Engineering and Medicine > Science > Life Sciences (2010- )
SWORD Depositor: Library Publications Router
Journal or Publication Title: The CRISPR Journal
Publisher: Mary Ann Liebert Inc
ISSN: 2573-1602
Official Date: 20 October 2020
Dates:
DateEvent
20 October 2020Published
1 October 2020Available
September 2020Accepted
Volume: 3
Number: 5
Page Range: pp. 398-408
DOI: 10.1089/crispr.2020.0029
Status: Peer Reviewed
Publication Status: Published
Access rights to Published version: Open Access (Creative Commons)
Copyright Holders: Copyright 2020, Mary Ann Liebert, Inc., publishers
Description:

Free access but no license on reuse

Request changes or add full text files to a record

Repository staff actions (login required)

View Item View Item
twitter

Email us: wrap@warwick.ac.uk
Contact Details
About Us